Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 114NIH 3OTHER_GOV 2FED 2NETWORK 1

Study Type

Observational 3Interventional 3

Sponsor

Conditions

Breast Neoplasms 411Lymphoma 304Carcinoma, Non-Small-Cell Lung 262Melanoma 255Precursor Cell Lymphoblastic Leukemia-Lymphoma 251Prostatic Neoplasms 246Leukemia, Lymphocytic, Chronic, B-Cell 242Leukemia, Myeloid, Acute 222Lung Neoplasms 215Neoplasms 209Colonic Neoplasms 209Lymphoma, Non-Hodgkin 207Lymphoma, Large B-Cell, Diffuse 204Leukemia 200Multiple Myeloma 197Lymphoma, Follicular 197Colorectal Neoplasms 190Rectal Neoplasms 188Ovarian Neoplasms 184Burkitt Lymphoma 179Brain Neoplasms 171Neoplasm Metastasis 166Lymphoma, Mantle-Cell 163Carcinoma, Renal Cell 163Glioblastoma 161Sarcoma 156Pancreatic Neoplasms 147Lymphoma, B-Cell, Marginal Zone 143Unspecified Adult Solid Tumor, Protocol Specific 138Gliosarcoma 133

Interventions

Bupropion 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Interventional × Smoking Cessation × Clear all
NCT02169271 2020-05-21

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

National Cancer Institute (NCI)

Phase 2 Completed
109 enrolled 27 charts

Tobacco Use Disorder, Smoking Cessation, Multiple Pulmonary Nodules

NCT01885052 2019-12-09

Evaluation of National Cancer Institute Young Adult Stop-Smoking Program

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
4,432 enrolled

Cigarette Smoking, Smoking, Smoking Cessation

NCT00322205 2017-01-11

Bio-behavioral Lung Cancer Prevention Program

National Institute on Drug Abuse (NIDA)

Phase 4 Completed
555 enrolled

Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡